REFERENCES
- Sheth B. B., Bandelin F. J., Shangraw R. F. Pharmaceutical Dosage Forms: Tablets. Marcel Dekker, New York 1980; 1: 109–185
- Doelker E., Mordier D., Iten H., Humbert-Droz P. Drug Dev. Ind. Pharm. 1987; 13: 1847–1875
- Bolhuis G. K., Zuurman K. Drug Dev. Ind. Pharm. 1995; 21: 2057–2071
- Flemming J., Mielck J. B. Drug Dev. Ind. Pharm. 1995; 21: 2239–2251
- Takami K., Machimura H., Inagaki M. Pharm. Tech. Jpn. 1996; 12: 431–435
- Takami K., Machimura H., Takado T., Inagaki M., Kawashima Y. Chem. Pharm. Bull. 1996; 44: 868–870
- Senjkovic R., Becirevie M., Usmiani I. Pharm. Ind. 1992; 54: 555–558
- Johnson M. C. R. Pharm. Acta Helv. 1972; 47: 546–559
- Johnson M. C. R. Pharm. Acta Helv. 1975; 50: 60–63
- Hersey J. A. Powder Technol. 1975; 11: 41–44
- Travers D. N. Powder Technol. 1975; 12: 189–190
- Egermann H. Powder Technol. 1983; 36: 117–118
- Egermann H. J. Pharmacol. 1985; 37: 491–492
- Staniforth J. N. J. Pharmacol. 1987; 39: 329–334
- Munoz-Ruiz A. Pharm. Acta Helv. 1992; 67: 223–226
- Shmidt P. C., Rubensdorfer C. J. W. Drug Dev. Ind. Pharm. 1994; 20: 2899–2925
- Shmidt P. C., Rubensdorfer C. J. W. Drug Dev. Ind. Pharm. 1994; 20: 2927–2952
- Kawashima Y., Cui F., Takeuchi H., Niwa T., Hino T., Kiuchi K. Pharm. Res. 1995; 12: 1040–1044
- Lerk C. F. Drug Dev. Ind. Pharm. 1993; 19: 2359–2398
- Otsuka A., Yakimoto T., Takeda A. Zairyou 1969; 18: 484–488
- Otsuka A., Yakimoto T., Takeda A. Yakuzaigaku 1969; 29: 263–266
- Korublum S. S., Stoobak S. B. J. Pharm. Sci. 1973; 62: 43–49
- Sadek H. M., Olsen J. L. Pharm. Technol. February 1981; 40–48
- Callahan J. C. Drug Dev. Ind. Pharm. 1982; 8: 355–369
- Otsuka A., Yakimoto T., Takeda A. Chem. Pharm. Bull. 1978; 26: 967–971
- Otsuka A., Yakimoto T., Takeda A. Yakugaku Zasshi 1976; 96: 351–355